(Q38109951)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714021%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714021%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

hepatocellular carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714021%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Xingshun Qi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714021%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Yan Zhao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714021%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Lin Zhou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714021%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Lei Liu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714021%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Ming Bai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714021%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Yongping Li

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714021%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Daiming Fan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714021%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Guohong Han

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714021%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

29 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714021%20AND%20SRC:MED&resulttype=core&format=json

Asia Pacific Journal of Clinical Oncology

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714021%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714021%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714021%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

357-364

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23714021%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Current strategy for staging and treatment: the BCLC update and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

From a cancer drug fund to value based pricing of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAJCO.12081